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Non-invasive ventilation in a university hospital 
intensive care unit: aspects related to success and 
failure
Ventilação não invasiva na unidade de terapia intensiva de um hospital universitário: 
características relacionadas ao sucesso e insucesso
Ventilación no invasiva en la unidad de terapia intensiva de un hospital universitario: 
características relacionadas con el éxito y el fracaso
Nair Fritzen dos Reis1, Nayala Lirio Gomes Gazola2, Daiana Cristine Bündchen3, Kelly Cattelan Bonorino4 
ABSTRACT | The objective of this study was to describe 
the aspects of success and failure of the use of non-
invasive ventilation (NIV) in the intensive care unit (ICU) 
of a university hospital. This is a prospective observational 
study that included 75 patients, with 58.3±18.8 years as 
the mean age. Of these, 12 required the use of NIV more 
than once, for 92 uses in total. Among these, the success 
rate was 60.9% (56). The failure group had more males 
(p=0.006) and a higher number of patients diagnosed with 
extrapulmonary infection (p=0.012). No differences were 
found between success and failure groups for the variables 
mode, model, mask, total length of stay and reasons for 
NIV installation. In the failure group, inspiratory positive 
airways pressure (Ipap) and flow volume (FV) were 
higher (p=0.029 and p=0.011, respectively). Peripheral 
oxygen saturation (p=0.047), pH (p=0.004), base excess 
(p=0.006) and bicarbonate (p=0.013) presented lower 
values. This study concluded that male individuals 
diagnosed with extrapulmonary infection and whose 
picture evolved with metabolic acidosis evolved with 
more failure in NIV use. These patients required higher 
Ipap and FV parameters.
Keywords | Critical Care; Artificial Breathing; Lung Ventilation.
RESUMO | O objetivo deste estudo foi descrever características 
de sucesso e insucesso do uso da ventilação não invasiva 
(VNI) na unidade de terapia intensiva (UTI) de um hospital 
universitário. Trata-se de um estudo observacional prospectivo 
no qual foram incluídos 75 pacientes, com idade média de 
58,3±18,8 anos. Desses, doze necessitaram do uso da VNI por 
mais de uma vez, totalizando 92 utilizações. Evidenciou-se que, 
delas, a taxa de sucesso foi de 60,9% (56). O grupo insucesso 
apresentou mais indivíduos do sexo masculino (p=0,006) 
e número maior de pacientes com diagnóstico de infecção 
extrapulmonar (p=0,012). Não foram encontradas diferenças 
entre os grupos de sucesso e insucesso nos quesitos de modo, 
modelo, máscara, tempo total de permanência e razões para 
a instalação da VNI. No grupo insucesso, a pressão positiva 
inspiratória nas vias aéreas (Ipap) e o volume corrente (VC) 
foram superiores (p=0,029 e p=0,011, respectivamente). 
A saturação periférica de oxigênio (p=0,047), o pH 
(p=0,004), base excess (p=0,006) e o bicarbonato (p=0,013) 
apresentaram valores inferiores. Concluiu-se que os indivíduos 
do sexo masculino com diagnóstico de infecção extrapulmonar 
e que evoluíram com acidose metabólica evoluíram com 
mais insucesso na utilização da VNI. Esses, necessitaram de 
parâmetros elevados de Ipap e VC.
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Descritores | Cuidados Críticos; Respiração Artificial; Ventilação 
Pulmonar.
RESUMEN | El objetivo de este estudio fue desarrollar las 
características del éxito y del fracaso con el uso de la ventilación no 
invasiva (VNI) en la unidad de terapia intensiva (UTI) de un hospital 
universitario. Se trata de un estudio observacional prospectivo en 
el cual fueron incluidos 75 pacientes, con edad media de 58,3±18,8 
años. De estos, 12 necesitaron utilizar la VNI por más de una vez, 
que totalizó 92 utilizaciones. Se evidenció que, de estas, el índice 
de éxito fue del 60,9% (56). El grupo que no obtuvo el éxito 
esperado presentó más individuos del sexo masculino (p=0,006) 
y número mayor de pacientes con diagnóstico de infecciones 
extrapulmonares (p=0,012). No fueron encontradas diferencias 
entre los grupos con éxito y sin éxito en las cuestiones de modo, 
modelo, máscara, tiempo total de permanencia y razones para 
la instalación de la VNI. En el grupo sin éxito, la presión positiva 
inspiratoria en las vías aéreas (Ipap) y el volumen corriente (VC) 
fueron superiores (p=0,029 y p=0,011, respectivamente). La 
saturación periférica de oxígeno (p=0,047), el pH(p=0,004), 
base excess (p=0,0006) y el bicarbonato (p=0,013) presentaron 
valores inferiores. De este modo, se concluye que los individuos del 
sexo masculino con diagnóstico de infecciones extrapulmonares 
y que progresaron con acidose metabólica avanzaron más sin 
tener éxito en la utilización de la VNI. Además, necesitaron de 
parámetros elevados de Ipap y VC.
Palabras clave | Cuidados Críticos; Respiración Artificial; Ventilación 
Pulmonar. 
INTRODUCTION
The use of non-invasive ventilation (NIV) for the 
treatment of patients with acute respiratory failure or acute 
chronic respiratory failure disease has been growing, being 
under growing development and having great importance 
in the field of mechanical ventilation1.
NIV use in patients with severe chronic obstructive 
pulmonary disease (COPD)2-5and acute pulmonary 
edema (APE)6-9 is responsible for decreasing the need 
for orotracheal intubation (OTI), mortality, and therapy 
costs10-12. Moreover, NIV is used as a weaning strategy 
in patients with repeated failures in the spontaneous 
breathing test and as a preventive way to prevent 
extubation failure in patients with risk factors13,14.
Searching for an effective, preventive and not as risky 
therapy for patients, studies in large hospitals have been 
developed to identify the profile of patients who use NIV15-
21, in addition to those with a strong recommendation for 
use (COPD and APE patients). The daily observation of 
the use of NIV in clinical practice and its limitations are 
potential targets for improving results in intensive care 
units (ICU), to improve the therapy offered to patients 
and to enable future research. Given this context, this 
study aimed to describe aspects of success and failure of 
the use of NIV in the ICU of a university hospital.
METHODOLOGY
This is a prospective observational study conducted from 
May to October 2014. Inclusion criteria were: patients 
older than 18 years old, of both sexes, who used NIV in the 
ICU of the University Hospital of Universidade Federal 
de Santa Catarina (HU/UFSC). The exclusion criterion 
was the lack of data in patients’ records.
Patients were evaluated and observed daily from 
admission to discharge from the ICU and hospital, or 
even death. Individuals who used NIV more than once 
during the hospitalization period were considered as a 
new individual, i.e., data analysis considered the total 
number of NIV uses. The decision for indicating and 
setting the NIV, and its parameters, was made by the 
multiprofessional team of this ICU.
Participants and/or responsible family members signed 
an informed consent form. This research was approved 
by the Research Ethics Committee on Human Beings of 
UFSC under CAAE no. 25677213.5.0000.0121.
Data were obtained from the filling of an evaluation 
form prepared by the authors and based on the literature. 
The analyzed variables were age, sex, origin, consciousness 
level, severity score, and clinical diagnosis. Regarding 
NIV: reason for use, total length of stay, modes, model, 
masks and parameters, arterial blood gas and vital signs.
Success in the use of NIV was considered as OTI 
prevention and not using NIV for more than 72 hour 
after discontinuation20. The need for OTI, regardless of 
the time of NIV use, was defined as failure20.
Continuous variables were expressed as mean and 
standard deviation (SD). Categorical variables were 
presented in frequency. Data normality was tested by 
the Kolmogorov-Smirnov test. Significant difference 
between groups was analyzed by the independent t-test 
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for the normal variables and by Mann-Whitney’s U test 
for non-parametric variables. The association between the 
categorical variables was analyzed using the Chi-square 
test or Fisher’s exact test. A p-value ≤0.05 was considered. 
All analyses were performed using the software SPSS 
Statistics, version 22.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
During the study period (five months), 328 patients 
were admitted to the ICU, of whom 80 used NIV. Five 
patients were excluded due to lack of information in their 
medical records. Twelve patients used NIV more than 
once during the hospitalization period, totaling 92 uses.
ICU Admissions
(May to October/2014)
n=328 patients
NIV
n=80 patients 
(25%)
NIV
n=75 patients 
(23%)
Excluded patients:
n=5
Lack of information
Patients who used 
NIV more than once
n=12
NIV
n=92 uses of NIV 
(28%)
NIV Success
n=56 (60.9%)
NIV Success
n=56 (60.9%)
Figure 1. Study design flowchart
ICU: Intensive Care Unit; NIV: Non-invasive ventilation.
Table 1 presents the values referring to sample 
characterization. The failure group had more males 
(p=0.006) and a higher number of patients diagnosed 
with extrapulmonary infection (p=0.012).
The success rate of NIV use was 60.9%. No differences 
were found between success and failure groups for the 
variables mode, model, mask, total length of stay and 
reasons for NIV installation. The most used mode was 
Bilevel (94.6%), on the Synchrony model (77.2%) and 
V60 (12.0%) with total face mask (98.9%). Most subjects 
were kept for less than 24 hours on NIV (51.1%), followed 
by those who used NIV for more than 48 hours (35.9%). 
Regarding the initial NIV parameters, it was observed 
that inspiratory positive airway pressure (Ipap) and flow 
volume (FV) were higher in the failure group (p=0.029 
and p=0.011), with an overall Ipap 15.9±2,8cmH2O mean 
and FV 575.6±165.2mL mean.
Table 1. Sample characterization
Variable Total n=75
Success
n=45 (60%)
Failure
n=30 (40%) p-value
General 
characteristics, 
mean±SD
Age (years) 58.3±18.1 56.3±20.1 61.3±14.4 0.414
Males, n (%) 33 (44) 14 (31.1) 19 (63.3) 0.006
Consciousness 
level (Glasgow 
scale)
13.3±2.03 13.4±1.9 13.2±2.1 0.718
SAPS III (points) 66.1±14.4 63.7±15.8 69.8±11.5 0.058
SAPS III (%) 49.2±25.1 45.2±27 55.2±21.2 0.08
Diagnosis for ICU 
admission, n (%)
Post-operative 
abdominal 
surgery
20 (26.7) 14 (31.1) 06 (20) 0.425
Lung infection 15 (20) 10 (22.2) 5 (16.7) 0.556
COPD 12 (16) 8 (17.8) 4 (13.3) 0.752
Extrapulmonary 
infection
10 (13.3) 2 (4.4) 8 (26.7) 0.012
APE 6 (8) 3 (6.7) 3 (10) 0.678
Onco-
hematological 
diseases
3 (4.6) 1 (2.2) 2 (6.7) 0.56
Asthma 2 (2.7) 2 (4.4) 0 (0) 0.514
Neuromuscular 
diseases
1 (1.3) 1 (2.2) 0 (0)
Others 6 (8) 4 (8.9) 2 (6.7)
Origin
Emergency 30 (40) 17 (37.8) 13 (43.3) 0.63
Surgical center 18 (24) 12 (26.7) 6 (20) 0.508
Other hospitals 15 (20) 10 (22.2) 5 (16.7) 0.556
Hospital Stay 12 (16) 6 (13.3) 6 (20) 0.44
Length of stay
Hospital (days) 27.5±26.7 25.7±19.3 30.3±35.2 0.918
ICU (days) 13.6±16 10.2±8.6 18.6±22.3 0.058
Method: Chi-square test. Fisher’s test. Student’s t-test. Mann-Whitney’s U test.
SAPS: Simplified Acute Physiology Score; ICU: Intensive Care Unit; COPD: Chronic Obstructive 
Pulmonary Disease; APE: Acute Pulmonary Edema.
Table 2 shows the analyses of arterial gases (n=83) 
and vital signs (n=92) prior to NIV use. Peripheral 
oxygen saturation value (p=0.047); pH, base excess 
and bicarbonate values were lower in the failure group 
(p=0.004, p=0.006 and p=0.013, respectively). The three 
later variables indicate metabolic disturbances.
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Table 2. Analysis of arterial gases and vital signs prior to NIV use
Variables Totaln=83
Success
n=51  
(61.45%)
Failure
n=32  
(38.55%)
p-value
Gasometry, mean±SD
pH 7.36±0.09 7.38±0.09 7.33±0.1 0.004
pCO2 (mmHg) 44.8±15.2 46.2±15.6 42.4±14.3 0.247
pO2 (mmHg) 113.6±46.4 115.4±49.2 110.7±41.9 0.658
SatO2(%) 95.1±8.2 94.7±9.8 95.8±4.4 0.614
BE (mEq / l) 0.4±9.7 2.6±9.5 -3.2±8.9 0.006
BIC (mEq/l) 26.4±12 28.9±13.1 22.1±8.5 0.013
Vital signs, mean±SD Total n=92
Success
n=56 
(60.9%)
Failure
n=36 
(39.1%)
SBP (mmHg) 134.2±30.1 137.3±31.8 129.3±26.8 0.214
DBP (mmHg) 74.4±16.8 76.5±16.1 71.2±17.5 0.143
FC (bpm) 101.8±19.8 101.3±18.5 102.6±21.9 0.753
FR (rpm) 24.6±9.5 24.2±8.2 25.2±11.3 0.63
SpO2(%) 93±7.9 94.9±5.1 90.1±10.4 0.047
Method: Student’s t-test. Mann-Whitney’s U test.
Pre-NIV: prior to the use of non-invasive ventilation; pH: potential hydrogen; pCO2: partial carbon 
dioxide pressure; pO2: partial oxygen pressure; SatO2: arterial oxygen saturation; BE: base excess; 
BIC: bicarbonate; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; RR: 
respiratory rate; SpO2: Peripheral oxygen saturation.
DISCUSSION
This study showed the use of NIV in different clinical 
conditions in the daily practice of an ICU, with a 60.9% 
success rate, confirming data found in other studies, which 
present success rates between 60 and 70%15,17,20,22-25.
Regarding the general characteristics of individuals, 
Yamauchi et al.20 identified that age was greater in 
individuals who evolved with NIV failure (p=0.003). This 
mean is similar to the one found in our study, however, 
we did not find differences between the groups.
Like Azevedo et al.21, Yamauchi et al.20 demonstrated 
that a high severity score at ICU admission is associated 
with NIV failure (SAPS II>34), but this was not found 
in our study.
The main diagnoses were post-operative of abdominal 
surgery, pulmonary infection, COPD and extrapulmonary 
infection. Similar rates of pulmonary and extrapulmonary 
infection, APE and COPD have been found in other 
studies21,26. We must highlight that patients admitted 
to the ICU with a extrapulmonary infection diagnosis 
evolved with NIV failure, probably due to the severity 
of the clinical picture.
In this study, there was no difference in the mean 
number of hospitalization days in the ICU and in 
the general hospital between groups, achieving results 
similar to those found by other authors21,25. However, 
some prospective studies have found that individuals who 
progressed with NIV failure remained hospitalized for 
longer periods in the ICU15,19,20. In the study by Antonelli 
et al.,15 it was demonstrated that NIV failure was related to 
a high risk of remaining in the ICU for more than seven 
days, as well as developing complications and progress 
to death in the ICU.
In most cases, NIV was used in a preventive measure 
to OTI (48.9%). As the first treatment option, NIV 
was used in 71% of the cases in the study by Girault. et 
al.25. On the other hand, other studies have shown rates 
ranging from 15 to 20%21,22. NIV as prevention measure 
for OTI is being used mainly in COPD patient, due to 
recommendations made for this population27. However, 
NIV use in different clinical conditions has also been 
observed28, such as in post-operative abdominal surgery, 
extrapulmonary infection and onco-hematologic diseases.
Literature presents great variation regarding the time 
of use of NIV. Some studies have shown a time of use 
from five hours to periods that exceed 72 hours24–26. In this 
study, NIV use for less than 24 hours was predominant and 
no differences in time of use were found between groups.
Regarding the initial NIV parameters, the failure group 
required mean Ipap values and higher FV values than 
the success group. Likewise, Yamauchi et al.20 identified 
higher Ipap values in the failure group (14-16cmH2O), 
similar to this study. Probably due to more severe cases 
such as individuals who required higher values in NIV 
in an attempt to avoid OTI or reintubation.
Regarding gasometry prior to NIV use, the failure 
group presented acidotic pH, similar to that found in 
Carlucci et al.22. However, these authors attributed the 
low pH to high partial CO2 pressure values. Differently 
from the findings of our study, in which acidosis was due 
to low bicarbonate values. Base excess and bicarbonate 
values were lower in the failure group. Rana et al.16 suggest 
that patients with low bicarbonate levels may be more 
susceptible to NIV failure.
Vital signs such as respiratory rate, heart rate, 
and systolic blood pressure found in this study were 
similar or lower, when compared to other findings in 
the literature16,17,29. The oxygenation analysis of the 
individuals in this study was performed through peripheral 
oxygen saturation, which was lower in the failure group. 
Rana et  al.16 used the gas exchange index and, likewise, 
showed that the failure group had lower values when 
compared to the success group.
NIV failure incidence (39.1%) found in this study was 
similar to the rates described by other authors15,17,20,22,24,25. 
On the other hand, some studies describe higher rates, 
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such as 50-74%16,19,21. The variation in NIV failure rate 
seems to be related to the cause of IRpA and to the 
severity of the disease15. In some studies, NIV failure was 
associated with factors such as clinical severity, presence of 
acute respiratory distress syndrome, age>40 years, positive 
water balance, SAPSII>34, pH<7.40, PaO2:FiO2146 
after 1 hour using NIV and Ipap15,16,21. Values similar to 
those found in the failure group of this study, such as: 
SAPS III> 69, pH=7.33 and Ipap>16.
The non-standardization of gasometric collection made 
it impossible to obtain blood gas values for comparing 
prior to and post-NIV use, and the non-establishment 
of a NIV protocol were the limitations of this study. A 
larger sample and other statistical analyses are required to 
infer predictive factors for failure in the ICU population.
CONCLUSION
Non-invasive ventilation was successfully used in 
most patients and in various clinical conditions in the 
ICU. Among patients admitted to the ICU during the 
study period, those with a diagnosis of extrapulmonary 
infection, males and with metabolic acidosis were the 
most unsuccessful cases. In addition, those whose clinical 
picture progressed with NIV failure required higher ICP 
and FV parameters.
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